Clinical Trial Update: Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 repeat-dose study evaluating safety and pharmacokinetics of controlled-release and immediate-release paroxetine tablets in healthy Japanese male subject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• Paroxetine (immediate-release) (paroxetine)
• Paroxetine controlled release (paroxetine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 1 | Status: COMPLETED